ESMO 2014

Oncology Meeting Resources

26 Sep - 30 Sep 2014, Madrid, Spain

ESMO 2014 Congress

The theme for ESMO 2014 was ‘Precision Medicine in Cancer Care.’ Whether you are a medical or surgical oncologist or a radiation oncologist, immunologist or pathologist, practising precision medicine means we are all working towards a common goal – improved patient outcomes. For your convenience and due to the large quantity of information coming from the ESMO 2014 congress, we have split the presentations up by main congress topic to allow you to find the information you need more easily.

Search through all presentations

Here, you will find the abstracts, posters, PDF presentation and webcasts from ESMO 2014 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Special Sessions and Tracks

Useful links





Format available

http://oncologypro.esmo.org/Meeting-Resourc...ration-of-systemic-therapy-in-common-tumours

Body Abstract:This presentation will focus on palliative first line chemotherapy (ChT) in breast, lung, colorectal and prostate cancer. For these tumors there is evidence that first line ChT improves...

Date: 27 Sep 2014
Presenter: Richard Herrmann
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Palliative Care

http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Conclusions

Date: 27 Sep 2014
Presenter: Michalis V. Karamouzis
Resources: Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Palliative Care

http://oncologypro.esmo.org/Meeting-Resourc...-to-stop-When-to-initiate-palliative-therapy

Body Abstract:Cancer patients are frequently submitted to chemotherapy in the end of life (EoL) with no apparent survival benefit and with decrease in quality of life.

Date: 27 Sep 2014
Presenter: Sofia Braga
Resources: Abstract, Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Palliative Care

http://oncologypro.esmo.org/Meeting-Resourc...l-oncologist-on-chemotherapy-intensification

BodyNo abstract received at time of going to press

Date: 27 Sep 2014
Presenter: Peter Schmid
Resources: Abstract, Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Palliative Care

http://oncologypro.esmo.org/Meeting-Resourc...s-palliation-for-people-with-advanced-cancer

Body Abstract:To benefit patients, treatment must improve either duration or quality of survival. For patients with minimal symptoms, one should only start palliative systemic treatment if there is...

Date: 27 Sep 2014
Presenter: Ian Tannock
Resources: Abstract, Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Palliative Care

http://oncologypro.esmo.org/Meeting-Resourc...y-survey-among-ESMO-National-Representatives

Date: 27 Sep 2014
Presenter: Robert Eckert
Resources: Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Palliative Care

http://oncologypro.esmo.org/Meeting-Resourc...lliative-treatment-of-advanced-breast-cancer

AimThe aim of the present study was to compare the effectiveness of cyclophosphamide-methotrexate ‘metronomic’ chemotherapy with the same regimen plus Imatinib in the palliative treatment of patients with metastatic breast cancer.

Date: 27 Sep 2014
Presenter: Zilola Olimova
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Breast Cancer, Metastatic, Palliative Care

http://oncologypro.esmo.org/Meeting-Resourc...-release-in-Korean-patients-with-cancer-pain

AimOxycodone/naloxone controlled release (CR) was developed for the management of opioid-induced constipation through the local antagonistic effect of naloxone in the gut wall, while maintaining analgesia...

Date: 28 Sep 2014
Presenter: Seongjoon Park
Resources: Abstract
Topic: Palliative Care

http://oncologypro.esmo.org/Meeting-Resourc...-multicenter-prospective-observational-study

AimEribulin (E) is a non taxane microtubule inhibitor indicated for treatment of MBC. To evaluate its tolerability, impact on Quality of Life (QoL) and symptoms improvement in MBC pts, from April 2012,...

Date: 28 Sep 2014
Presenter: Lucia Mentuccia
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Breast Cancer, Metastatic, Palliative Care

http://oncologypro.esmo.org/Meeting-Resourc...s-in-advanced-terminally-ill-cancer-patients

AimOnly advanced/terminally ill cancer patients who are aware of their prognoses can participate in discussions about their end-of-life (EOL) treatments and make the decisions that meet their preferences.

Date: 28 Sep 2014
Presenter: Chen Chen
Resources: Abstract
Topics: Palliative Care, Patient Education